These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 39402578)
1. Nanoplatelets modified with RVG for targeted delivery of miR-375 and temozolomide to enhance gliomas therapy. Yang T; Zhang N; Liu Y; Yang R; Wei Z; Liu F; Song D; Wang L; Wei J; Li Y; Shen D; Liang G J Nanobiotechnology; 2024 Oct; 22(1):623. PubMed ID: 39402578 [TBL] [Abstract][Full Text] [Related]
2. Development of transferrin-modified poly(lactic-co-glycolic acid) nanoparticles for glioma therapy. Mao J; Meng X; Zhao C; Yang Y; Liu G Anticancer Drugs; 2019 Jul; 30(6):604-610. PubMed ID: 30855310 [TBL] [Abstract][Full Text] [Related]
3. MiR-181b-5p modulates chemosensitivity of glioma cells to temozolomide by targeting Bcl-2. Zhang X; Yu J; Zhao C; Ren H; Yuan Z; Zhang B; Zhuang J; Wang J; Feng B Biomed Pharmacother; 2019 Jan; 109():2192-2202. PubMed ID: 30551476 [TBL] [Abstract][Full Text] [Related]
4. MSC-AS1 knockdown inhibits cell growth and temozolomide resistance by regulating miR-373-3p/CPEB4 axis in glioma through PI3K/Akt pathway. Li C; Feng S; Chen L Mol Cell Biochem; 2021 Feb; 476(2):699-713. PubMed ID: 33106913 [TBL] [Abstract][Full Text] [Related]
6. Fabrication of pH-responsive temozolomide (TMZ)-clacked tannic acid-altered zeolite imidazole nanoframeworks (ZIF-8) enhance anticancer activity and apoptosis induction in glioma cancer cells. Ren C; Tu Q; He J J Biomater Sci Polym Ed; 2024 Sep; 35(13):1978-1998. PubMed ID: 38953298 [TBL] [Abstract][Full Text] [Related]
7. Hsa_circ_0110757 upregulates ITGA1 to facilitate temozolomide resistance in glioma by suppressing hsa-miR-1298-5p. Li H; Liu Q; Chen Z; Wu M; Zhang C; Su J; Li Y; Zhang C Cell Death Dis; 2021 Mar; 12(3):252. PubMed ID: 33674567 [TBL] [Abstract][Full Text] [Related]
9. Combined Delivery of Temozolomide and siPLK1 Using Targeted Nanoparticles to Enhance Temozolomide Sensitivity in Glioma. Shi H; Sun S; Xu H; Zhao Z; Han Z; Jia J; Wu D; Lu J; Liu H; Yu R Int J Nanomedicine; 2020; 15():3347-3362. PubMed ID: 32494134 [TBL] [Abstract][Full Text] [Related]
10. Preparation of transferrin-targeted temozolomide nano-micelles and their anti-glioma effect. Yu J; Xue Y PeerJ; 2024; 12():e17979. PubMed ID: 39285923 [TBL] [Abstract][Full Text] [Related]
11. Vincristine and temozolomide combined chemotherapy for the treatment of glioma: a comparison of solid lipid nanoparticles and nanostructured lipid carriers for dual drugs delivery. Wu M; Fan Y; Lv S; Xiao B; Ye M; Zhu X Drug Deliv; 2016 Oct; 23(8):2720-2725. PubMed ID: 26203691 [TBL] [Abstract][Full Text] [Related]
12. Efficient antiglioblastoma therapy in mice through doxorubicin-loaded nanomicelles modified using a novel brain-targeted RVG-15 peptide. Han M; Xing H; Chen L; Cui M; Zhang Y; Qi L; Jin M; Yang Y; Gao C; Gao Z; Xing X; Huang W J Drug Target; 2021 Nov; 29(9):1016-1028. PubMed ID: 33825602 [TBL] [Abstract][Full Text] [Related]
13. miR-1297 sensitizes glioma cells to temozolomide (TMZ) treatment through targeting adrenomedullin (ADM). He Z; Cheng M; Hu J; Liu L; Liu P; Chen L; Cao D; Tang J J Transl Med; 2022 Oct; 20(1):443. PubMed ID: 36183123 [TBL] [Abstract][Full Text] [Related]
14. Mustard-inspired delivery shuttle for enhanced blood-brain barrier penetration and effective drug delivery in glioma therapy. Wang N; Sun P; Lv M; Tong G; Jin X; Zhu X Biomater Sci; 2017 May; 5(5):1041-1050. PubMed ID: 28378865 [TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of nano-PTX to the brain tumor-associated macrophages. Zou L; Tao Y; Payne G; Do L; Thomas T; Rodriguez J; Dou H Oncotarget; 2017 Jan; 8(4):6564-6578. PubMed ID: 28036254 [TBL] [Abstract][Full Text] [Related]
16. Knockdown of circHIPK3 Facilitates Temozolomide Sensitivity in Glioma by Regulating Cellular Behaviors Through miR-524-5p/KIF2A-Mediated PI3K/AKT Pathway. Yin H; Cui X Cancer Biother Radiopharm; 2021 Sep; 36(7):556-567. PubMed ID: 32833501 [No Abstract] [Full Text] [Related]
17. Use of surface-modified porous silicon nanoparticles to deliver temozolomide with enhanced pharmacokinetic and therapeutic efficacy for intracranial glioblastoma in mice. Shin S; Jo H; Agura T; Jeong S; Ahn H; Kim Y; Kang JS J Mater Chem B; 2024 Sep; 12(37):9335-9344. PubMed ID: 39171683 [TBL] [Abstract][Full Text] [Related]
18. MicroRNA-302c enhances the chemosensitivity of human glioma cells to temozolomide by suppressing P-gp expression. Wu Y; Yao Y; Yun Y; Wang M; Zhu R Biosci Rep; 2019 Sep; 39(9):. PubMed ID: 31409725 [TBL] [Abstract][Full Text] [Related]
19. Aplysin enhances temozolomide sensitivity in glioma cells by increasing miR-181 level. Gong A; Ge N; Yao W; Lu L; Liang H Cancer Chemother Pharmacol; 2014 Sep; 74(3):531-8. PubMed ID: 25047724 [TBL] [Abstract][Full Text] [Related]
20. Enhanced efficacy of combined temozolomide and bromodomain inhibitor therapy for gliomas using targeted nanoparticles. Lam FC; Morton SW; Wyckoff J; Vu Han TL; Hwang MK; Maffa A; Balkanska-Sinclair E; Yaffe MB; Floyd SR; Hammond PT Nat Commun; 2018 May; 9(1):1991. PubMed ID: 29777137 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]